- Home
- OBIO vs OSUR Comparison
OBIO vs OSUR Comparison
Compare OBIO & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- OSUR
- Stock Information
- Founded
- OBIO 2017
- OSUR 2000
- Country
- OBIO United States
- OSUR United States
- Employees
- OBIO N/A
- OSUR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- OSUR Medical/Dental Instruments
- Sector
- OBIO Health Care
- OSUR Health Care
- Exchange
- OBIO Nasdaq
- OSUR Nasdaq
- Market Cap
- OBIO 205.0M
- OSUR 334.1M
- IPO Year
- OBIO N/A
- OSUR 1986
- Fundamental
- Price
- OBIO $5.83
- OSUR $4.13
- Analyst Decision
- OBIO Strong Buy
- OSUR Buy
- Analyst Count
- OBIO 4
- OSUR 3
- Target Price
- OBIO $15.75
- OSUR $6.67
- AVG Volume (30 Days)
- OBIO 44.2K
- OSUR 459.6K
- Earning Date
- OBIO 11-11-2024
- OSUR 11-05-2024
- Dividend Yield
- OBIO N/A
- OSUR N/A
- EPS Growth
- OBIO N/A
- OSUR N/A
- EPS
- OBIO N/A
- OSUR 0.36
- Revenue
- OBIO $2,079,000.00
- OSUR $273,535,000.00
- Revenue This Year
- OBIO $7.68
- OSUR N/A
- Revenue Next Year
- OBIO $110.40
- OSUR N/A
- P/E Ratio
- OBIO N/A
- OSUR $11.35
- Revenue Growth
- OBIO N/A
- OSUR N/A
- 52 Week Low
- OBIO $4.22
- OSUR $3.92
- 52 Week High
- OBIO $11.69
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- OBIO 60.54
- OSUR 45.49
- Support Level
- OBIO $5.20
- OSUR $4.00
- Resistance Level
- OBIO $5.99
- OSUR $4.16
- Average True Range (ATR)
- OBIO 0.38
- OSUR 0.08
- MACD
- OBIO 0.12
- OSUR 0.01
- Stochastic Oscillator
- OBIO 87.20
- OSUR 57.89
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.